NCT06007768 Autoimmune and Inflammatory Response Biomarkers in Fabry Disease Status COMPLETED Phase N/A
NCT05843916 Switch Over Study of Biosimilar Agalsidase Beta for Fabry Disease Status COMPLETED Phase PHASE3
NCT05761834 FASHION Fabry Disease Hypertrophic Cardiomyopathy and Infammation Status UNKNOWN Phase N/A
NCT05710692 Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease Status RECRUITING Phase PHASE2/PHASE3
NCT05710367 Effects Of Sodium Glucose Cotranspoter 2 Inhibitors On Heart And Kidneys In Fabry Disease Patients Status UNKNOWN Phase PHASE2
NCT05699265 Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing Status TERMINATED Phase N/A
NCT05698901 Biomarkers and Cardiac Imaging Diagnostic Assay for Monitoring Patients With Fabry Disease Status RECRUITING Phase N/A
NCT05679076 A Qualitative Study on the Pain and Quality of Life of Patients With Fabry Disease Status UNKNOWN Phase N/A
NCT05671770 Study Based on Electronic Health RecOrds to Identify Patients at High-risk of Fabry DiseasE (HOPE Fabry) Status COMPLETED Phase N/A
NCT05629559 4D-310 in Adults With Fabry Disease and Cardiac Involvement Status RECRUITING Phase PHASE1/PHASE2
NCT05473637 Taiwan Associated Genetic and Nongenetic Small Vessel Disease Status RECRUITING Phase N/A
NCT05409846 Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies Status COMPLETED Phase N/A
NCT05368038 ScreenPlus: A Comprehensive, Flexible, Multi-disorder Newborn Screening Program Status ENROLLING_BY_INVITATION Phase N/A
NCT05343715 PK/PD Study of 2 Agalsidase Formulations in Single Dose of 1 mg/kg Administered to Healthy Volunteers as IV Infusion Status COMPLETED Phase PHASE1
NCT05280548 A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05206773 A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05186324 Fabry Patient's Experience Of PegunigaLsidasE Alfa Monthly Infusion Status COMPLETED Phase N/A